Debt-to-equity of 89bio, Inc. from 31 Mar 2022 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
89bio, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2022 to 30 Jun 2025.
  • 89bio, Inc. Debt-to-equity for the quarter ending 30 Jun 2025 was 17%, a 35% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

89bio, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2025 17% +4.4% +35% 30 Jun 2025
Q1 2025 16% +4.1% +34% 31 Mar 2025
Q4 2024 16% +4.8% +42% 31 Dec 2024
Q3 2024 14% +0.76% +5.7% 30 Sep 2024
Q2 2024 12% -3.7% -23% 30 Jun 2024
Q1 2024 12% -13% -52% 31 Mar 2024
Q4 2023 11% -28% -71% 31 Dec 2023
Q3 2023 13% -27% -67% 30 Sep 2023
Q2 2023 16% -19% -54% 30 Jun 2023
Q1 2023 25% +7% +38% 31 Mar 2023
Q4 2022 40% 31 Dec 2022
Q3 2022 40% 30 Sep 2022
Q2 2022 35% 30 Jun 2022
Q1 2022 18% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.